{
    "nctId": "NCT00508352",
    "briefTitle": "Post-operative Radiation With IMRT in the Management of Stage IIB-III Breast Cancer",
    "officialTitle": "Post-operative Locoregional Irradiation Using Helical Tomotherapy IMRT in the Management of Stage IIb-III Breast Cancer: a Feasibility Study",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "Acute radiation effects(less than 90 days post treatment)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Surgery with either mastectomy or breast conserving surgery\n2. Presence and association of any of the following high risk pathological features present at time of surgery: stage pT3-4 and pN0 and central/medial location of tumour or any pT and pN2 (stage IIB-stage III)\n3. All patients will have been treated previously with chemotherapy prior to radiation therapy\n4. ECOG performance status of 2 or less\n\nExclusion Criteria:\n\n1. Prior chest wall/breast or nodal radiation for other malignancies (i.e. Hodgkin disease)\n2. HER2+ positive patients\n3. Patients with diagnosis of metastatic disease\n4. Prior or active malignancy except non-melanoma skin carcinoma within 5 years of the diagnosis of breast cancer",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}